Overcoming the hurdle of fluorescent compounds in kinase screening: A case study

Assay and Drug Development Technologies

Volumn 4, Issue 2, 2006, Pages 185-196

  Perrin, Dominique ^a   Martin, Thierry ^a   Cambet, Yves ^a   Frémaux, Christèle ^a   Scheer, Alexander ^a  

^a SERONO PHARMACEUTICAL RES INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHOSPHATE BINDING AGENT; PHOSPHOTRANSFERASE; STAUROSPORINE;

ANALYTICAL EQUIPMENT; ARTICLE; AUTOFLUORESCENCE; BIOLUMINESCENCE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DATA ANALYSIS; ENZYME ASSAY; FLUORESCENCE ANALYSIS; FLUORESCENCE POLARIZATION; IC 50; MOLECULAR WEIGHT; SCINTILLATION; SCREENING TEST; SENSITIVITY ANALYSIS; STANDARD;

CHEMILUMINESCENT MEASUREMENTS; FLUORESCENCE POLARIZATION IMMUNOASSAY; FLUORESCENT DYES; MICROFLUIDIC ANALYTICAL TECHNIQUES; PROTEIN-SERINE-THREONINE KINASES; SCINTILLATION COUNTING; SENSITIVITY AND SPECIFICITY;

EID: 33744523183     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2006.4.185     Document Type: Article

References (27)

1. Vlahos CJ, McDowell SA, Clerck A: Kinases as therapeutic targets for heart failure. Nat Rev Drug Discov 2003; 2:99-113.
2. Fabbro D, Garcia-Etchevarria C: Targeting protein kinases in cancer therapy. Curr Opin Drug Discov Dev 2002;5: 701-712.
3. Orchard S: Kinases as targets: prospects for chronic therapy. Curr Opin Drug Discov Dev 2002;5:713-717.
4. Adjei AA, Hidalgo M: Intracellular signal transduction pathway proteins as targets for cancer therapy. J Clin Oncol 2005;23:5386-5403.
5. Smith JK, Mamoon NM, Duhé RJ: Emerging roles of targeted small molecule protein-tyrosine kinase inhibitors in cancer therapy. Oncol Res 2004;14:175-225.
6. Manley PW, Cowan-Jacob SW, Buchdunger E, Fabbro D, Fendrich G, Furet P, Meyer T, Zimmerman J: Imatinib: a selective tyrosine kinase inhibitor. Eur J Cancer 2002; 38(Suppl):S19-S27.
7. Cohen P: Protein kinases - the major drug targets of the twenty-first century? Nat Rev Drug Discov 2002;1: 309-315.
8. Parker GJ, Law TL, Lenoch FJ, Bolger RE: Development of high throughput screening assays using fluorescence polarization: nuclear receptor-ligand-binding and kinase/phosphatase assays. J Biomol Screen 2000;5:77-88.
9. Zaman GJR, Garritsen A, de Boer T, van Boeckel CAA: Homogeneous assays for adenosine 5′-monophosphate-activated protein kinase. Comb Chem High Throughput Screen 2003;6:313-320.
10. Gaudet EA, Huang KS, Zhang Y, Huang W, Mark D, Sportsman JR: A homogeneous fluorescence polarization assay adaptable for a range of serine/threonine and tyrosine kinases. J Biomol Screen 2003;8:164-175.
11. Xia W, Rininsland F, Wittenburg SK, Shi X, Achyutan KE, McBranch DW, Whitten DG: Applications of fluorescent polymer superquenching to high throughput screening assays. Assay Drug Dev Technol 2004;2:183-192.
12. Pope AJ: Introduction LANCE™ vs. HTRF® technologies (or vice versa). J Biomol Screen 1999;4:301-302.
13. Ohml N, Wingfield JM, Yazawa H, Inagaki O: Development of a homogeneous time-resolved fluorescence assay for high throughput screening to identify Lck inhibitors: comparison with scintillation proximity assay and streptavidin-coated plate assay. J Biomol Screen 2005;5:463-470.
14. Dunne J, Reardon H, Trinh V, Ella L, Farinas J: Comparison of on-chip and off-chip microfluidic kinase assay formats. Assay Drug Dev Technol 2004;2:121-129.
15. Pommereau A, Everard P, Kannt A: Two simple and generic antibody-independent kinase assays: comparison of a bioluminescent and a microfluidic assay format. J Biomol Screen 2004;9:409-416.
16. Vainshtein I, Silveria S, Kaul P, Rouhani R, Eglen RM, Wang J: A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP). J Biomol Screen 2002;7:507-514.
17. Von Leoprechting A, Kumpf R, Menzel S, Reulle D, Griebel R, Valler MJ, Büttner FH: Miniaturization and validation of a high-throughput serine kinase assay using the Alpha Screen platform. J Biomol Screen 2004;9:719-725.
18. Sills MA, Weiss D, Pham Q, Schweitzer R, Wu X, Wu JJ: Comparison of assay technologies for a tyrosine kinase assay generates different results in high throughput screening. J Biomol Screen 2002;7:191-214.
19. Beasley JR, McCoy PM, Walker TL, Dunn DA: Miniaturized, ultra-high throughput screening of tyrosine kinases using homogeneous, competitive fluorescence immunoassays. Assay Drug Dev Technol 2004;2:141-151.
20. Beasley JR, Dunn DA, Walker TL, Parlato SM, Lehrach JM, Auld DS: Evaluation of compound interference in immobilized metal ion affinity-based fluorescence polarization detection with a four million member compound collection. Assay Drug Dev Technol 2003;1:455-459.
21. Zhang J-H, Chung TDY, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4:67-73.
22. Loomans EEMG, van Doormalen AM, Wat JWY, Zaman GJR: High-throughput screening with immobilized metal ion affinity based fluorescence polarization detection, a homogeneous assay for protein kinases. Assay Drug Dev Technol 2003;1:455-459.
23. Coffin J, Latev M, Xiahui B, Nifikorov TT: Detection of phosphopeptides by fluorescence polarization in the presence of cationic polyamino acids: application to kinase assays. Anal Biochem 2000;278:206-212.
24. Turek-Etienne TC, Lei M, Terraciano JS, Langsdorf EF, Bryant RW, Hart RF, Horan AC: Use of red-shifted dyes in a fluorescence polarization AKT kinase assay for detection of biological activity in natural product extracts. J Biomol Screen 2004;9:52-61.
25. Fabian MA, Biggs WH 3rd, Treiber DK, Atteridge CE, Azimioara MD, Benedetti MG, Carter TA, Ciceri P, Edeen PT, Floyd M, Ford JM, Galvin M, Gerlach JL, Grotzfeld RM, Herrgard S, Insko DE, Insko MA, Lai AG, Lelias JM, Mehta SA, Milanov ZV, Velasco AM, Wodicka LM, Patel HK, Zarrinkar PP, Lockhart DJ: A small molecule-kinase interaction map for clinical kinase inhibitors. Nat Biotechnol 2005;3:308-309.
26. Bain J, McLauchlan H, Elliott M, Cohen P: The specificities of protein kinase inhibitors: an update. Biochem J 2003;371:199-204.
27. 2). J Org Chem 2002;67:5454-5460.